ArticleFrontiers in pharmacology2024

IL-23 inhibitor enhances the effects of PTEN DNA-loaded lipid nanoparticles for metastatic CRPC therapy.

Xinlu Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.